AiDAPT Trial

AiDAPT is a randomised controlled trial comparing automated closed-loop and standard insulin delivery for pregnant women with type I diabetes

[AiDAPT Trial @AidaptTrial]

Excited to announce the publication of the AiDAPT post-partum results! https://t.co/RsnJV6PTe9

[Diabetologia @DiabetologiaJnl]

This review outlines some of the extraordinary recent advances in diabetes technology, which are transforming the management of diabetes before, during and after pregnancy. @AidaptTrial https://t.co/9xoJQ5I8N4 🔓

[AiDAPT Trial @AidaptTrial]

The NIHR @AidaptTrial final report is now publicly available https://t.co/fmCx5LlEK4 Thanks again for the support. We’re excited to have started the real-world implementation across the NHS

[CamDiab @CamAPS_FX]

🚨BREAKING NEWS🚨

We have something BIG to report

CamDiab has secured @US_FDA 🇺🇸 approval for our advanced adaptive hybrid closed-loop app CamAPS FX

Read more⬇️
https://t.co/fapohOmD1v

Thanks to @Cambridge_Uni for sharing the story⬇️
https://t.co/qCexeoKWeM

@_RomanHovorka

[AiDAPT Trial @AidaptTrial]

Amazing news! Congratulations @_RomanHovorka @CamAPS_FX, it’s an honour to have worked with you

[AiDAPT Trial @AidaptTrial]

Supporting the rollout of HCL and CamAPS in pregnancy #InsulinSafetyWeek #HCL #CamAPS @CamAPS_FX #diabetesinpregnancy

[AiDAPT Trial @AidaptTrial]

Don't miss Prof Murphy & Dr Tara Lee talking about system-specific benefits of closed-loop in pregnancy this afternoon! Free to attend, all welcome - register here: https://t.co/WDje0W66J7

[AiDAPT Trial @AidaptTrial]

This session will cover an update of current evidence for different HCL systems in pregnancy and also updated tips and tricks optimising for the use of the CamAPS system in pregnancy including labour, delivery and immediate postpartum

[📰Diabetes Times @DiabetesTimes]

🎙️ NEW PODCAST ALERT 🎙️

Episode 14 of the Talking #Diabetes #podcast is now live.

In this episode we spoke to Professor Helen Murphy and Professor Roman Hovorka at the #DUKPC2024 about hybrid closed loop systems.

Listen here➡️https://t.co/rOa62Jx4ct

[AiDAPT Trial @AidaptTrial]

The NIHR Evidence summary of ‘Automated Insulin Delivery in Women with Pregnancy Complicated by Type 1 Diabetes’ has now been published @NIHREvidence

[AiDAPT Trial @AidaptTrial]

@MaitlandRahat Absolutely, please do!

[AiDAPT Trial @AidaptTrial]

Delighted to share the @AidaptTrial results infographic. Thanks to everyone who took part, the future looks good for #T1Dpregnancy. The NICE technical appraisal means that NHS Trusts can start to offer #hybridclosedloop to pregnant women and women planning pregnancy

[Breakthrough T1D UK @BT1DUK]

“I felt more trust in my own body.”

Nina Willer has spoken to us about taking part in the @AidaptTrial, which studied the effect of using #HybridClosedLoop technology during pregnancy 🤰🔁

Read Nina's full story: https://t.co/UFHtIH0Sbf

#Type1Diabetes #T1D #GBDoc

[NEJM @NEJM]

Presented today at #EASD2023:

The AiDAPT trial randomly assigned pregnant women with type 1 diabetes to standard insulin therapy with continuous glucose monitoring or to hybrid closed-loop therapy. The latter significantly improved maternal glycemic control.

@EASDnews

[Emma Wilmot @WilmotEmma]

Wow!

Clinical practice changing NEJM publication!

Congratulations to Tara Lee, Helen Murphy, @TIME_research, @_RomanHovorka & all involved in this paper:

AiDAPT RCT of AID shows a 10.5% diff in TIR in pregnant women with T1DM vs control

#EASD2023

https://t.co/LP5tSnkwz6

[AiDAPT Trial @AidaptTrial]

@ERobertson02 @LalanthaL https://t.co/J0AUmNp1eH

[AiDAPT Trial @AidaptTrial]

@ERobertson02 @LalanthaL https://t.co/T4P6IRjkUz

[AiDAPT Trial @AidaptTrial]

Excited to also share the incredibly important qualitative women's views paper #AiDAPTresults #EASD2023

Supporting the use of #hybridclosedloop in #T1Dpregnancy

https://t.co/J0AUmNp1eH

[AiDAPT Trial @AidaptTrial]

Thrilled to share the published results! Enormous thanks to all participants, site staff, and collaborators that made this happen #EASD2023 #T1D #hybridclosedloop

Automated Insulin Delivery in Women with Pregnancy Complicated by Type 1 Diabetes | NEJM https://t.co/T4P6IRjSK7

[AiDAPT Trial @AidaptTrial]

As Professor Helen Murphy presents the @AidaptTrial results at #EASD, very excited to share this news

[Breakthrough T1D UK @BT1DUK]

🚨 Breaking news 🚨

A JDRF-supported trial has shown that #HybridClosedLoop technology helps pregnant women better manage their blood sugars compared to traditional insulin pumps or multiple daily injections 🤰🔁

Read more: https://t.co/ZxUe2uHFUq

@EASDnews #EASD2023 #GBDoc